First Time Loading...

Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 56.48 USD 0.39% Market Closed
Updated: Mar 28, 2024

Catalent Inc
Capital Expenditures

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Catalent Inc
Capital Expenditures Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Catalent Inc
NYSE:CTLT
Capital Expenditures
$-437m
CAGR 3-Years
13%
CAGR 5-Years
-20%
CAGR 10-Years
-15%
Johnson & Johnson
NYSE:JNJ
Capital Expenditures
$-4.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Capital Expenditures
$-1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-5%
CAGR 10-Years
-8%
Pfizer Inc
NYSE:PFE
Capital Expenditures
$-3.9B
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Merck & Co Inc
NYSE:MRK
Capital Expenditures
$-3.9B
CAGR 3-Years
4%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Capital Expenditures
$-7.4B
CAGR 3-Years
-54%
CAGR 5-Years
-20%
CAGR 10-Years
-21%

See Also

What is Catalent Inc's Capital Expenditures?
Capital Expenditures
-437m USD

Based on the financial report for Dec 31, 2023, Catalent Inc's Capital Expenditures amounts to -437m USD.

What is Catalent Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-15%

Over the last year, the Capital Expenditures growth was 38%. The average annual Capital Expenditures growth rates for Catalent Inc have been 13% over the past three years , -20% over the past five years , and -15% over the past ten years .